{"cdcTestId":"2013-0222","testcaseName":"Dose 1 to dose 3 interval of Comvax 16 wks-5 days. 4th dose needed","vaccineGroup":"HepB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2002-11-16T00:00:00","patient":{"dob":"2002-05-15T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2002-08-01T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2002-09-20T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2002-11-16T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2002-11-21T00:00:00","recommendedDate":"2002-11-21T00:00:00","pastDueDate":"2004-01-11T00:00:00"},"doses":[{"dateAdministered":"2002-08-01T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2002-09-20T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2002-11-16T00:00:00","vaccineName":"COMVAX","cvx":"51","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:04:09.868","generalDescription":"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 5 days from dose #1 that the dose is valid, but a 4th dose is needed to complete the series.","changedInVersion":"4.2","reasonForChange":"V4.2: Updated Forecast Test Type to \u0022Recommended based on interval\u0022\nV4.1: Changed forecast to reflect new 4 dose guidance from CEB.\nv3.1: Changed dose 3 from not valid to valid due to recent clarifications."}